Literature DB >> 26581423

Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel.

A Lerner1,2,3, E Solter4,5, E Rachi4,6,5, A Adler4,6,5, H Rechnitzer7,8, D Miron7,8, L Krupnick7,8, S Sela9,8, E Aga9,8, Y Ziv9,8, A Peretz10,8, K Labay10,8, G Rahav10,8, Y Geffen11,12, K Hussein11,12, O Eluk11,12, Y Carmeli4,5, M J Schwaber4,5.   

Abstract

Since 2013, four hospitals in northern Israel have been providing care for Syrian nationals, primarily those wounded in the ongoing civil war. We analyzed carbapenemase-producing Enterobacteriaceae (CPE) isolates obtained from these patients. Isolate identification was performed using the VITEK 2 system. Polymerase chain reaction (PCR) was performed for the presence of bla KPC, bla NDM, and bla OXA-48. Susceptibility testing and genotyping were performed on selected isolates. During the study period, 595 Syrian patients were hospitalized, most of them young men. Thirty-two confirmed CPE isolates were grown from cultures taken from 30 patients. All but five isolates were identified as Klebsiella pneumoniae and Escherichia coli. Nineteen isolates produced NDM and 13 produced OXA-48. Among a further 29 isolates tested, multilocus sequence typing (MLST) showed that ST278 and ST38 were the major sequence types among the NDM-producing K. pneumoniae and OXA-48-producing E. coli isolates, respectively. Most were resistant to all three carbapenems in use in Israel and to gentamicin, but susceptible to colistin and fosfomycin. The source for bacterial acquisition could not be determined; however, some patients admitted to different medical centers were found to carry the same sequence type. CPE containing bla NDM and bla OXA-48 were prevalent among Syrian wounded hospitalized patients in northern Israel. The finding of the same sequence type among patients at different medical centers implies a common, prehospital source for these patients. These findings have implications for public health throughout the region.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26581423     DOI: 10.1007/s10096-015-2520-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter.

Authors:  Vered Schechner; Tali Kotlovsky; Jalal Tarabeia; Meital Kazma; David Schwartz; Shiri Navon-Venezia; Yehuda Carmeli
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

2.  Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus.

Authors:  Anette M Hammerum; Anders R Larsen; Frank Hansen; Ulrik S Justesen; Alice Friis-Møller; Lars E Lemming; Kurt Fuursted; Pia Littauer; Kristian Schønning; Bente Gahrn-Hansen; Svend Ellermann-Eriksen; Brian Kristensen
Journal:  Int J Antimicrob Agents       Date:  2012-06-27       Impact factor: 5.283

3.  Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention.

Authors:  Mitchell J Schwaber; Boaz Lev; Avi Israeli; Ester Solter; Gill Smollan; Bina Rubinovitch; Itamar Shalit; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2011-02-11       Impact factor: 9.079

4.  Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism.

Authors:  Amos Adler; Maya Shklyar; Mitchell J Schwaber; Shiri Navon-Venezia; Yacoub Dhaher; Rotem Edgar; Ester Solter; Shmuel Benenson; Samira Masarwa; Yehuda Carmeli
Journal:  J Antimicrob Chemother       Date:  2011-12       Impact factor: 5.790

Review 5.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

Review 6.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 7.  Treating infections caused by carbapenemase-producing Enterobacteriaceae.

Authors:  L S Tzouvelekis; A Markogiannakis; E Piperaki; M Souli; G L Daikos
Journal:  Clin Microbiol Infect       Date:  2014-07-12       Impact factor: 8.067

8.  The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece.

Authors:  Evangelia Voulgari; Constantina Gartzonika; Georgia Vrioni; Lida Politi; Efthalia Priavali; Stamatina Levidiotou-Stefanou; Athanassios Tsakris
Journal:  J Antimicrob Chemother       Date:  2014-04-15       Impact factor: 5.790

9.  Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial.

Authors:  Ilana Oren; Hannah Sprecher; Renato Finkelstein; Salim Hadad; Ami Neuberger; Keatam Hussein; Ayelet Raz-Pasteur; Noa Lavi; Elias Saad; Israel Henig; Netanel Horowitz; Irit Avivi; Noam Benyamini; Riva Fineman; Yishai Ofran; Nuhad Haddad; Jacob M Rowe; Tsila Zuckerman
Journal:  Am J Infect Control       Date:  2013-12       Impact factor: 2.918

10.  Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).

Authors:  Monica Österblad; Juha Kirveskari; Antti J Hakanen; Päivi Tissari; Martti Vaara; Jari Jalava
Journal:  J Antimicrob Chemother       Date:  2012-07-31       Impact factor: 5.790

View more
  11 in total

1.  Whole-genome sequencing of Klebsiella pneumoniae MDR strain isolated in a Syrian refugee.

Authors:  Silvia Angeletti; Eleonora Cella; Alessia Lai; Alessandra Lo Presti; Francesca Antonelli; Alessia Conti; Maurizio Lopalco; Silvia Spoto; Gianguglielmo Zehender; Massimo Ciccozzi
Journal:  Pathog Glob Health       Date:  2017-04-12       Impact factor: 2.894

Review 2.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

Review 3.  The rapid spread of carbapenem-resistant Enterobacteriaceae.

Authors:  Robert F Potter; Alaric W D'Souza; Gautam Dantas
Journal:  Drug Resist Updat       Date:  2016-09-19       Impact factor: 18.500

Review 4.  OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors:  Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

Review 5.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

6.  Molecular Evolution of a Klebsiella pneumoniae ST278 Isolate Harboring blaNDM-7 and Involved in Nosocomial Transmission.

Authors:  Tarah Lynch; Liang Chen; Gisele Peirano; Dan B Gregson; Deirdre L Church; John Conly; Barry N Kreiswirth; Johann D Pitout
Journal:  J Infect Dis       Date:  2016-06-09       Impact factor: 5.226

7.  Antibiotic resistance during and beyond COVID-19.

Authors:  David M Livermore
Journal:  JAC Antimicrob Resist       Date:  2021-06-15

8.  Multidrug-Resistant Pathogens in Hospitalized Syrian Children.

Authors:  Diana Faour Kassem; Yoav Hoffmann; Naama Shahar; Smadar Ocampo; Liora Salomon; Zeev Zonis; Daniel Glikman
Journal:  Emerg Infect Dis       Date:  2017-01-15       Impact factor: 6.883

9.  A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Authors:  Oryan Henig; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Steve Marshall; Susan D Rudin; T Nicholas Domitrovic; Andrea M Hujer; Kristine M Hujer; Yohei Doi; Scott Evans; Vance G Fowler; Robert A Bonomo; David van Duin; Keith S Kaye
Journal:  Open Forum Infect Dis       Date:  2017-07-27       Impact factor: 3.835

Review 10.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.